miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques.

Conclusions: Our results provide insight into the immune mechanisms and cellular players that execute anti-miR-33's atheroprotective actions in the plaque.
PMID: 33593073 [PubMed - as supplied by publisher]

Source: Circulation Research - February 17, 2021 Category: Cardiology Authors: Afonso MS, Sharma M, Schlegel MP, van Solingen C, Koelwyn GJ, Shanley LC, Beckett L, Peled D, Rahman K, Giannarelli C, Li H, Brown EJ, Khodadadi-Jamayran A, Fisher EA, Moore KJ Tags: Circ Res Source Type: research